Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, May 2, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
Life Sciences Times
-
May 1, 2026
Pharma
FDA Advisory Panel Backs AstraZeneca’s TRUQAP Combination for PTEN-Deficient Prostate Cancer
Life Sciences Times
-
May 1, 2026
Pharma
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
Life Sciences Times
-
April 30, 2026
Pharma
Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study
Life Sciences Times
-
April 30, 2026
Pharma
Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment
Life Sciences Times
-
April 30, 2026
Pharma
BeiGene Announces Positive Findings from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy in First-Line Gastric or Gastroesophageal Junction Cancer
Life Sciences Times
-
January 24, 2022
0
Pharma
Panavance Announces Abstract and Poster at ASCO Gastrointestinal Cancers Symposium, Providing an Update on the Status of GP-2250 Clinical Trial
Life Sciences Times
-
January 19, 2022
0
Pharma
Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and Provides Strategy Update
Life Sciences Times
-
January 18, 2022
0
Pharma
DC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTA
Life Sciences Times
-
January 18, 2022
0
Pharma
Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™
Life Sciences Times
-
January 18, 2022
0
Pharma
Alnylam to Present Full 18-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran at the Société Francophone du Nerf Périphérique Annual Meeting
Life Sciences Times
-
January 14, 2022
0
Pharma
n-Lorem Foundation Announces New Publication in Trends in Molecular Medicine
Life Sciences Times
-
January 13, 2022
0
Pharma
Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Antibiotic Cefepime/enmetazobactam in Europe
Life Sciences Times
-
January 13, 2022
0
Pharma
Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary...
Life Sciences Times
-
January 12, 2022
0
Pharma
Hemogenyx Pharmaceuticals and Selexis SA Will Advance Hemogenyx’s Acute Myeloid Leukemia (AML) CDX Bispecific Antibody to Human Trials
Life Sciences Times
-
January 12, 2022
0
Pharma
Panavance Therapeutics Inc. Created to Transform Cancer Treatment
Life Sciences Times
-
January 11, 2022
0
Pharma
Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer
Life Sciences Times
-
January 10, 2022
0
1
...
62
63
64
...
91
Page 63 of 91
Most Read
Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board
May 1, 2026
SK Capital Completes Sale of Noramco Group Businesses to Siegfried
May 1, 2026
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
May 1, 2026
Seaport Therapeutics Prices Upsized IPO at $18 Per Share
May 1, 2026